breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
Predicted mutations | |||||||
---|---|---|---|---|---|---|---|
evidence | seq id | position | mutation | freq | annotation | gene | description |
RA | NZ_CP022686 | 124,727 | A→C | 5.6% | intergenic (‑127/‑72) | CIW80_RS00635 ← / → CIW80_RS00640 | PTS sugar transporter subunit IIB/GntR family transcriptional regulator |
RA | NZ_CP022686 | 133,814 | C→A | 8.6% | A476A (GCG→GCT) | ydfI ← | mannitol dehydrogenase family protein |
RA | NZ_CP022686 | 197,824 | T→G | 5.2% | V460G (GTA→GGA) | dtpA → | dipeptide/tripeptide permease DtpA |
RA | NZ_CP022686 | 210,318 | A→C | 7.9% | intergenic (+19/‑18) | nemR → / → nemA | DNA‑binding transcriptional regulator NemR/N‑ethylmaleimide reductase |
RA | NZ_CP022686 | 236,044 | G→T | 19.5% | R353L (CGT→CTT) | pykF → | pyruvate kinase PykF |
RA | NZ_CP022686 | 238,323 | A→C | 24.4% | F86V (TTT→GTT) | sufE ← | cysteine desulfuration protein SufE |
RA | NZ_CP022686 | 263,831 | A→C | 9.2% | intergenic (+38/+19) | fadK → / ← ppsA | medium‑chain fatty‑acid‑‑CoA ligase/phosphoenolpyruvate synthase |
RA | NZ_CP022686 | 269,554 | A→C | 11.3% | G269G (GGT→GGG) | selO ← | protein adenylyltransferase SelO |
RA | NZ_CP022686 | 340,485 | A→C | 7.6% | V41G (GTT→GGT) | ydjK ← | MFS transporter |
RA | NZ_CP022686 | 364,743 | T→G | 8.6% | intergenic (‑178/+27) | fadD ← / ← yeaY | long‑chain‑fatty‑acid‑‑CoA ligase FadD/Slp family lipoprotein YeaY |
RA | NZ_CP022686 | 364,775 | C→A | 8.7% | E193* (GAA→TAA) | yeaY ← | Slp family lipoprotein YeaY |
RA | NZ_CP022686 | 418,374 | T→G | 9.1% | F48V (TTT→GTT) | znuB → | zinc ABC transporter permease subunit ZnuB |
RA | NZ_CP022686 | 457,894 | Δ1 bp | 100% | pseudogene (288/997 nt) | CIW80_RS02445 ← | DUF968 domain‑containing protein |
RA | NZ_CP022686 | 524,842 | T→G | 9.1% | V203G (GTC→GGC) | yedE → | selenium metabolism membrane protein YedE/FdhT |
RA | NZ_CP022686 | 531,408 | A→C | 10.3% | K44N (AAA→AAC) | fliF → | flagellar basal‑body MS‑ring/collar protein FliF |
JC | NZ_CP022686 | 532,627 | +TGCTGGC | 8.8% | coding (1351/1659 nt) | fliF → | flagellar basal‑body MS‑ring/collar protein FliF |
RA | NZ_CP022686 | 560,880 | C→T | 100% | intergenic (+62/+53) | CIW80_RS03085 → / ← pilV | hypothetical protein/shufflon system plasmid conjugative transfer pilus tip adhesin PilV |
RA | NZ_CP022686 | 596,637 | T→G | 12.5% | G54G (GGT→GGG) | irp1 → | yersiniabactin polyketide synthase HMWP1 |
RA | NZ_CP022686 | 601,295 | T→G | 17.4% | V1607G (GTC→GGC) | irp1 → | yersiniabactin polyketide synthase HMWP1 |
RA | NZ_CP022686 | 601,302 | T→G | 20.4% | R1609R (CGT→CGG) | irp1 → | yersiniabactin polyketide synthase HMWP1 |
MC JC | NZ_CP022686 | 628,478 | Δ1,286 bp | 100% | [clbP] | [clbP] | |
RA | NZ_CP022686 | 651,833 | A→C | 10.6% | P243P (CCT→CCG) | clbJ ← | colibactin non‑ribosomal peptide synthetase ClbJ |
RA | NZ_CP022686 | 694,406 | G→T | 10.4% | intergenic (+166/‑30) | CIW80_RS03555 → / → CIW80_RS03560 | transposase/PfkB family carbohydrate kinase |
RA | NZ_CP022686 | 694,421 | G→T | 8.0% | intergenic (+181/‑15) | CIW80_RS03555 → / → CIW80_RS03560 | transposase/PfkB family carbohydrate kinase |
RA | NZ_CP022686 | 694,457 | G→T | 8.5% | E8* (GAA→TAA) | CIW80_RS03560 → | PfkB family carbohydrate kinase |
RA | NZ_CP022686 | 756,115 | A→G | 100% | G181G (GGT→GGC) | galE ← | UDP‑glucose 4‑epimerase GalE |
RA | NZ_CP022686 | 764,997 | T→G | 15.1% | N41T (AAC→ACC) | wcaM ← | colanic acid biosynthesis protein WcaM |
RA | NZ_CP022686 | 766,756 | C→G | 18.7% | D291H (GAC→CAC) | wcaK ← | colanic acid biosynthesis pyruvyl transferase WcaK |
RA | NZ_CP022686 | 794,460 | C→T | 100% | A568V (GCG→GTG) | dgcE → | diguanylate cyclase |
RA | NZ_CP022686 | 829,441 | C→A | 21.2% | intergenic (‑30/+197) | gatY ← / ← fbaB | tagatose‑bisphosphate aldolase subunit GatY/class I fructose‑bisphosphate aldolase |
RA | NZ_CP022686 | 829,448 | T→A | 10.1% | intergenic (‑37/+190) | gatY ← / ← fbaB | tagatose‑bisphosphate aldolase subunit GatY/class I fructose‑bisphosphate aldolase |
RA | NZ_CP022686 | 829,452 | G→T | 20.1% | intergenic (‑41/+186) | gatY ← / ← fbaB | tagatose‑bisphosphate aldolase subunit GatY/class I fructose‑bisphosphate aldolase |
RA | NZ_CP022686 | 829,472 | G→T | 12.8% | intergenic (‑61/+166) | gatY ← / ← fbaB | tagatose‑bisphosphate aldolase subunit GatY/class I fructose‑bisphosphate aldolase |
RA | NZ_CP022686 | 829,513 | C→A | 12.3% | intergenic (‑102/+125) | gatY ← / ← fbaB | tagatose‑bisphosphate aldolase subunit GatY/class I fructose‑bisphosphate aldolase |
RA | NZ_CP022686 | 837,555 | T→G | 15.3% | intergenic (‑128/+95) | thiM ← / ← rcnR | hydroxyethylthiazole kinase/Ni(II)/Co(II)‑binding transcriptional repressor RcnR |
RA | NZ_CP022686 | 837,573 | C→A | 18.1% | intergenic (‑146/+77) | thiM ← / ← rcnR | hydroxyethylthiazole kinase/Ni(II)/Co(II)‑binding transcriptional repressor RcnR |
RA | NZ_CP022686 | 859,923 | C→G | 7.9% | S595C (TCT→TGT) | yehM → | DUF5682 family protein |
RA | NZ_CP022686 | 881,760 | T→G | 16.5% | intergenic (+275/+112) | yohP → / ← dusC | protein YohP/tRNA dihydrouridine(16) synthase DusC |
RA | NZ_CP022686 | 917,427:1 | +TT | 100% | intergenic (+130/‑91) | yeiP → / → yeiQ | elongation factor P‑like protein YeiP/mannitol dehydrogenase family protein |
RA | NZ_CP022686 | 948,080 | G→T | 13.7% | intergenic (+149/‑108) | CIW80_RS04855 → / → CIW80_RS04860 | terminase small subunit/hypothetical protein |
RA | NZ_CP022686 | 948,090 | C→A | 14.9% | intergenic (+159/‑98) | CIW80_RS04855 → / → CIW80_RS04860 | terminase small subunit/hypothetical protein |
RA | NZ_CP022686 | 948,114 | T→G | 10.8% | intergenic (+183/‑74) | CIW80_RS04855 → / → CIW80_RS04860 | terminase small subunit/hypothetical protein |
RA | NZ_CP022686 | 955,932 | A→C | 5.4% | F41V (TTC→GTC) | ccmC ← | heme exporter protein CcmC |
RA | NZ_CP022686 | 957,112 | T→G | 8.7% | T89P (ACC→CCC) | ccmA ← | cytochrome c biogenesis heme‑transporting ATPase CcmA |
RA | NZ_CP022686 | 1,000,418 | T→G | 10.7% | T949T (ACA→ACC) | yfaL ← | AIDA‑I family autotransporter adhesin YfaL/EhaC |
RA | NZ_CP022686 | 1,005,085 | C→A | 9.2% | T380T (ACC→ACA) | nrdA → | ribonucleoside‑diphosphate reductase subunit alpha |
RA | NZ_CP022686 | 1,034,493 | T→G | 8.2% | T26P (ACC→CCC) | menC ← | o‑succinylbenzoate synthase |
RA | NZ_CP022686 | 1,065,997 | A→C | 11.1% | A30A (GCT→GCG) | yfbS ← | SLC13 family permease |
RA | NZ_CP022686 | 1,100,944 | T→G | 12.2% | D187A (GAC→GCC) | aroC ← | chorismate synthase |
RA | NZ_CP022686 | 1,120,323 | A→T | 6.0% | T2558T (ACT→ACA) | CIW80_RS05650 ← | phase‑variable autotransporter adhesin UpaE |
RA | NZ_CP022686 | 1,145,575 | C→A | 9.4% | E332* (GAA→TAA) | oxc ← | oxalyl‑CoA decarboxylase |
RA | NZ_CP022686 | 1,172,453 | C→A | 9.7% | D125E (GAC→GAA) | yfeD → | putative DNA‑binding transcriptional regulator |
RA | NZ_CP022686 | 1,172,467 | C→A | 12.3% | A130E (GCA→GAA) | yfeD → | putative DNA‑binding transcriptional regulator |
RA | NZ_CP022686 | 1,174,272 | A→C | 10.6% | intergenic (+1/‑43) | CIW80_RS05855 → / → CIW80_RS05860 | tRNA‑Val/tRNA‑Val |
RA | NZ_CP022686 | 1,209,908 | T→G | 17.5% | D396A (GAC→GCC) | eutH ← | ethanolamine utilization protein EutH |
RA | NZ_CP022686 | 1,269,551 | T→G | 8.1% | K1124N (AAA→AAC) | CIW80_RS06320 ← | DUF823 domain‑containing adhesin |
RA | NZ_CP022686 | 1,280,117 | T→G | 6.2% | N8H (AAC→CAC) | yfgM ← | ancillary SecYEG translocon subunit YfgM |
RA | NZ_CP022686 | 1,319,588 | T→G | 10.2% | E332D (GAA→GAC) | glyA ← | serine hydroxymethyltransferase |
RA | NZ_CP022686 | 1,360,724 | G→T | 7.1% | intergenic (‑59/+265) | kgtP ← / ← rrf | alpha‑ketoglutarate permease/5S ribosomal RNA |
RA | NZ_CP022686 | 1,360,729 | G→T | 7.4% | intergenic (‑64/+260) | kgtP ← / ← rrf | alpha‑ketoglutarate permease/5S ribosomal RNA |
RA | NZ_CP022686 | 1,360,742 | C→A | 6.4% | intergenic (‑77/+247) | kgtP ← / ← rrf | alpha‑ketoglutarate permease/5S ribosomal RNA |
RA | NZ_CP022686 | 1,366,277 | T→G | 6.8% | intergenic (‑278/+164) | CIW80_RS06740 ← / ← clpB | 16S ribosomal RNA/ATP‑dependent chaperone ClpB |
RA | NZ_CP022686 | 1,371,066 | T→A | 7.7% | V27E (GTA→GAA) | bamD → | outer membrane protein assembly factor BamD |
RA | NZ_CP022686 | 1,371,081 | C→A | 14.4% | P32Q (CCA→CAA) | bamD → | outer membrane protein assembly factor BamD |
RA | NZ_CP022686 | 1,371,086 | G→T | 21.1% | E34* (GAA→TAA) | bamD → | outer membrane protein assembly factor BamD |
RA | NZ_CP022686 | 1,371,092 | T→A | 12.9% | Y36N (TAC→AAC) | bamD → | outer membrane protein assembly factor BamD |
RA | NZ_CP022686 | 1,441,726 | A→C | 8.8% | L612V (TTA→GTA) | hypF ← | carbamoyltransferase HypF |
RA | NZ_CP022686 | 1,441,772 | A→C | 7.9% | R596R (CGT→CGG) | hypF ← | carbamoyltransferase HypF |
RA | NZ_CP022686 | 1,460,615 | A→C | 10.7% | K673N (AAA→AAC) | flhA → | formate hydrogenlyase transcriptional activator FlhA |
RA | NZ_CP022686 | 1,484,873 | C→A | 7.0% | intergenic (‑208/+57) | CIW80_RS07420 ← / ← cysH | Hok/Gef family protein/phosphoadenosine phosphosulfate reductase |
RA | NZ_CP022686 | 1,504,258 | G→T | 10.2% | S232I (AGT→ATT) | CIW80_RS07520 → | YgcG family protein |
RA | NZ_CP022686 | 1,504,351 | A→C | 8.4% | N263T (AAC→ACC) | CIW80_RS07520 → | YgcG family protein |
RA | NZ_CP022686 | 1,504,355 | T→A | 9.4% | A264A (GCT→GCA) | CIW80_RS07520 → | YgcG family protein |
RA | NZ_CP022686 | 1,504,361 | G→T | 15.6% | V266V (GTG→GTT) | CIW80_RS07520 → | YgcG family protein |
RA | NZ_CP022686 | 1,504,373 | G→C | 10.3% | K270N (AAG→AAC) | CIW80_RS07520 → | YgcG family protein |
RA | NZ_CP022686 | 1,510,233 | A→C | 5.1% | V599G (GTT→GGT) | relA ← | GTP pyrophosphokinase |
RA | NZ_CP022686 | 1,547,110 | G→C | 15.0% | intergenic (+22/‑12) | CIW80_RS07710 → / → CIW80_RS07715 | tRNA‑Met/tRNA‑Met |
RA | NZ_CP022686 | 1,564,569 | A→C | 10.6% | K190N (AAA→AAC) | CIW80_RS07780 → | ImcF‑related family protein |
RA | NZ_CP022686 | 1,579,273 | G→T | 6.2% | I120I (ATC→ATA) | CIW80_RS07835 ← | PRD domain‑containing protein |
RA | NZ_CP022686 | 1,579,310 | G→C | 6.6% | S108* (TCA→TGA) | CIW80_RS07835 ← | PRD domain‑containing protein |
RA | NZ_CP022686 | 1,579,312 | A→C | 8.5% | V107V (GTT→GTG) | CIW80_RS07835 ← | PRD domain‑containing protein |
RA | NZ_CP022686 | 1,597,266 | C→G | 7.2% | M8I (ATG→ATC) | thyA ← | thymidylate synthase |
RA | NZ_CP022686 | 1,632,501 | T→G | 8.5% | V166G (GTT→GGT) | arcC → | carbamate kinase |
RA | NZ_CP022686 | 1,632,508 | C→A | 8.0% | I168I (ATC→ATA) | arcC → | carbamate kinase |
RA | NZ_CP022686 | 1,633,846 | T→G | 24.8% | N253T (AAC→ACC) | yqeB ← | selenium‑dependent molybdenum cofactor biosynthesis protein YqeB |
RA | NZ_CP022686 | 1,640,888 | G→T | 12.5% | intergenic (+34/‑17) | ssnA → / → ygfM | putative aminohydrolase SsnA/molybdopterin‑dependent oxidoreductase FAD‑binding subunit |
RA | NZ_CP022686 | 1,640,925 | A→C | 13.0% | R7S (AGA→AGC) | ygfM → | molybdopterin‑dependent oxidoreductase FAD‑binding subunit |
RA | NZ_CP022686 | 1,674,231 | A→T | 11.2% | V186E (GTA→GAA) | ygfB ← | UPF0149 family protein YgfB |
RA | NZ_CP022686 | 1,674,244 | T→G | 11.7% | T182P (ACC→CCC) | ygfB ← | UPF0149 family protein YgfB |
RA | NZ_CP022686 | 1,674,248 | T→G | 8.6% | Q180H (CAA→CAC) | ygfB ← | UPF0149 family protein YgfB |
RA | NZ_CP022686 | 1,716,167 | A→C | 13.0% | N49T (AAC→ACC) | rdgB → | XTP/dITP diphosphatase |
RA | NZ_CP022686 | 1,734,237 | A→G | 100% | W156R (TGG→CGG) | papX ← | HTH‑type transcriptional regulator PapX |
RA | NZ_CP022686 | 1,758,771 | T→G | 5.8% | intergenic (+18/‑254) | sat → / → CIW80_RS08700 | serine protease autotransporter toxin Sat/transposase |
RA | NZ_CP022686 | 1,828,110 | A→C | 6.1% | R85R (CGT→CGG) | gspK ← | type II secretion system minor pseudopilin GspK |
RA | NZ_CP022686 | 1,832,023 | T→G | 8.8% | N355T (AAC→ACC) | gspE ← | type II secretion system ATPase GspE |
RA | NZ_CP022686 | 1,833,768 | A→C | 14.9% | M460R (ATG→AGG) | gspD ← | type II secretion system secretin GspD |
RA | NZ_CP022686 | 1,925,332 | A→C | 9.7% | N151T (AAC→ACC) | ygiB → | DUF1190 family protein |
RA | NZ_CP022686 | 1,925,353 | G→T | 7.6% | G158V (GGT→GTT) | ygiB → | DUF1190 family protein |
RA | NZ_CP022686 | 1,954,923 | T→G | 17.1% | T92P (ACG→CCG) | ttdR ← | DNA‑binding transcriptional activator TtdR |
RA | NZ_CP022686 | 1,954,955 | T→G | 12.1% | Q81P (CAG→CCG) | ttdR ← | DNA‑binding transcriptional activator TtdR |
RA | NZ_CP022686 | 1,975,137 | A→C | 6.0% | intergenic (+6/‑57) | ebgC → / → ygjI | beta‑galactosidase subunit beta/amino acid permease |
RA | NZ_CP022686 | 2,016,160 | T→G | 5.7% | noncoding (114/377 nt) | rnpB ← | RNase P RNA component class A |
RA | NZ_CP022686 | 2,016,170 | A→C | 9.8% | noncoding (104/377 nt) | rnpB ← | RNase P RNA component class A |
RA | NZ_CP022686 | 2,016,175 | T→G | 6.7% | noncoding (99/377 nt) | rnpB ← | RNase P RNA component class A |
RA | NZ_CP022686 | 2,032,739 | G→T | 6.9% | W24L (TGG→TTG) | agaC → | PTS galactosamine transporter subunit IIC |
RA | NZ_CP022686 | 2,037,521 | A→C | 10.9% | T508P (ACC→CCC) | lpoA → | penicillin‑binding protein activator LpoA |
RA | NZ_CP022686 | 2,047,984 | A→C | 5.5% | R624R (CGT→CGG) | deaD ← | ATP‑dependent RNA helicase DeaD |
RA | NZ_CP022686 | 2,049,089 | T→G | 16.7% | N256T (AAC→ACC) | deaD ← | ATP‑dependent RNA helicase DeaD |
RA | NZ_CP022686 | 2,049,094 | G→T | 8.1% | T254T (ACC→ACA) | deaD ← | ATP‑dependent RNA helicase DeaD |
RA | NZ_CP022686 | 2,056,102 | A→C | 5.3% | A636A (GCT→GCG) | infB ← | translation initiation factor IF‑2 |
RA | NZ_CP022686 | 2,056,168 | A→C | 9.2% | G614G (GGT→GGG) | infB ← | translation initiation factor IF‑2 |
RA | NZ_CP022686 | 2,061,767 | A→C | 6.1% | N379T (AAC→ACC) | argG → | argininosuccinate synthase |
RA | NZ_CP022686 | 2,061,805 | G→C | 7.1% | G392R (GGC→CGC) | argG → | argininosuccinate synthase |
RA | NZ_CP022686 | 2,070,788 | A→C | 6.7% | intergenic (‑80/‑169) | greA ← / → dacB | transcription elongation factor GreA/serine‑type D‑Ala‑D‑Ala carboxypeptidase |
RA | NZ_CP022686 | 2,110,457 | T→G | 10.2% | K12N (AAA→AAC) | rplM ← | 50S ribosomal protein L13 |
RA | NZ_CP022686 | 2,110,685 | A→C | 12.1% | intergenic (‑193/+27) | rplM ← / ← zapE | 50S ribosomal protein L13/cell division protein ZapE |
RA | NZ_CP022686 | 2,130,829 | A→C | 8.7% | V237G (GTT→GGT) | mreC ← | rod shape‑determining protein MreC |
RA | NZ_CP022686 | 2,148,109 | T→G | 9.8% | V124G (GTG→GGG) | panF → | sodium/pantothenate symporter |
RA | NZ_CP022686 | 2,148,115 | T→G | 12.9% | L126R (CTG→CGG) | panF → | sodium/pantothenate symporter |
RA | NZ_CP022686 | 2,148,118 | C→G | 14.9% | A127G (GCG→GGG) | panF → | sodium/pantothenate symporter |
RA | NZ_CP022686 | 2,148,136 | T→G | 13.1% | V133G (GTT→GGT) | panF → | sodium/pantothenate symporter |
RA | NZ_CP022686 | 2,148,141 | T→G | 14.3% | F135V (TTC→GTC) ‡ | panF → | sodium/pantothenate symporter |
RA | NZ_CP022686 | 2,148,143 | C→G | 13.1% | F135L (TTC→TTG) ‡ | panF → | sodium/pantothenate symporter |
RA | NZ_CP022686 | 2,159,660 | G→T | 12.0% | D163Y (GAT→TAT) | CIW80_RS10780 → | amino acid ABC transporter substrate‑binding protein |
RA | NZ_CP022686 | 2,172,177 | A→C | 5.6% | G87G (GGT→GGG) | smg ← | DUF494 family protein Smg |
RA | NZ_CP022686 | 2,184,330 | G→T | 15.7% | F64L (TTC→TTA) | rplO ← | 50S ribosomal protein L15 |
RA | NZ_CP022686 | 2,185,075 | A→C | 8.4% | V46G (GTT→GGT) | rpsE ← | 30S ribosomal protein S5 |
RA | NZ_CP022686 | 2,188,239 | G→T | 6.1% | intergenic (‑108/+57) | rplN ← / ← rpsQ | 50S ribosomal protein L14/30S ribosomal protein S17 |
RA | NZ_CP022686 | 2,214,419 | T→C | 100% | K43R (AAA→AGA) | rpsL ← | 30S ribosomal protein S12 |
RA | NZ_CP022686 | 2,272,798 | C→G | 7.5% | intergenic (+40/‑57) | greB → / → yhgF | transcription elongation factor GreB/Tex family protein |
RA | NZ_CP022686 | 2,272,810 | T→G | 8.8% | intergenic (+52/‑45) | greB → / → yhgF | transcription elongation factor GreB/Tex family protein |
RA | NZ_CP022686 | 2,284,668 | A→C | 7.7% | R207R (CGT→CGG) | malQ ← | 4‑alpha‑glucanotransferase |
RA | NZ_CP022686 | 2,310,429 | T→G | 7.0% | N248T (AAC→ACC) | glgP ← | glycogen phosphorylase |
RA | NZ_CP022686 | 2,320,775 | C→T | 100% | G274S (GGC→AGC) | CIW80_RS11675 ← | DNA‑processing protein DprA |
RA | NZ_CP022686 | 2,357,291 | A→C | 12.3% | N26T (AAC→ACC) | dcrB → | phage sensitivity protein DcrB |
RA | NZ_CP022686 | 2,357,324 | A→C | 21.2% | N37T (AAC→ACC) | dcrB → | phage sensitivity protein DcrB |
RA | NZ_CP022686 | 2,361,489 | T→G | 11.8% | V188G (GTT→GGT) | nikA → | nickel ABC transporter substrate‑binding protein |
RA | NZ_CP022686 | 2,362,607 | T→G | 6.3% | L36R (CTT→CGT) | nikB → | nickel ABC transporter permease subunit NikB |
RA | NZ_CP022686 | 2,386,496 | T→G | 9.7% | K417N (AAA→AAC) | prlC ← | oligopeptidase A |
RA | NZ_CP022686 | 2,393,013 | T→G | 5.2% | intergenic (+151/‑2) | slp → / → dctR | outer membrane lipoprotein Slp/LuxR C‑terminal‑related transcriptional regulator |
RA | NZ_CP022686 | 2,394,287 | T→G | 16.8% | N115T (AAC→ACC) | chuS ← | hematinate‑forming heme oxygenase ChuS |
RA | NZ_CP022686 | 2,394,291 | C→A | 9.5% | E114* (GAA→TAA) | chuS ← | hematinate‑forming heme oxygenase ChuS |
RA | NZ_CP022686 | 2,394,295 | G→T | 7.6% | I112I (ATC→ATA) | chuS ← | hematinate‑forming heme oxygenase ChuS |
RA | NZ_CP022686 | 2,394,339 | C→A | 7.7% | D98Y (GAT→TAT) | chuS ← | hematinate‑forming heme oxygenase ChuS |
RA | NZ_CP022686 | 2,408,861 | Δ1 bp | 100% | pseudogene (1097/3115 nt) | mdtF → | multidrug efflux pump RND permease MdtF |
RA | NZ_CP022686 | 2,460,576 | C→A | 13.3% | M1M (ATG→ATT) † | yhjY ← | autotransporter outer membrane beta‑barrel domain‑containing protein |
RA | NZ_CP022686 | 2,516,638 | C→A | 8.0% | T683N (ACC→AAC) | upaG → | trimeric autotransporter adhesin UpaG |
RA | NZ_CP022686 | 2,516,872 | A→C | 6.4% | K761T (AAA→ACA) ‡ | upaG → | trimeric autotransporter adhesin UpaG |
RA | NZ_CP022686 | 2,516,873 | A→C | 7.9% | K761N (AAA→AAC) ‡ | upaG → | trimeric autotransporter adhesin UpaG |
RA | NZ_CP022686 | 2,546,394 | A→C | 12.1% | V95G (GTT→GGT) | waaG ← | glycosyltransferase family 4 protein |
RA | NZ_CP022686 | 2,546,400 | A→C | 15.0% | L93R (CTG→CGG) | waaG ← | glycosyltransferase family 4 protein |
RA | NZ_CP022686 | 2,550,368 | T→G | 5.7% | G130G (GGA→GGC) | mutM ← | bifunctional DNA‑formamidopyrimidine glycosylase/DNA‑(apurinic or apyrimidinic site) lyase |
JC | NZ_CP022686 | 2,590,563 | +TTGG | 100% | coding (109/153 nt) | CIW80_RS26455 → | hypothetical protein |
RA | NZ_CP022686 | 2,643,652 | T→G | 7.9% | D433A (GAC→GCC) | dnaA ← | chromosomal replication initiator protein DnaA |
RA | NZ_CP022686 | 2,701,400 | G→T | 5.5% | R328S (CGC→AGC) | mdtD ← | multidrug transporter subunit MdtD |
RA | NZ_CP022686 | 2,703,299 | A→C | 7.3% | intergenic (‑203/‑277) | yieP ← / → CIW80_RS13540 | FadR/GntR family transcriptional regulator/16S ribosomal RNA |
RA | NZ_CP022686 | 2,743,563 | T→G | 13.5% | noncoding (65/87 nt) | CIW80_RS13750 → | tRNA‑Leu |
RA | NZ_CP022686 | 2,769,166 | C→A | 11.3% | C57F (TGC→TTC) | rarD ← | EamA family transporter RarD |
RA | NZ_CP022686 | 2,769,196 | A→C | 16.7% | F47C (TTT→TGT) | rarD ← | EamA family transporter RarD |
RA | NZ_CP022686 | 2,773,056 | T→G | 6.9% | V51G (GTT→GGT) | rhtC → | threonine export protein RhtC |
RA | NZ_CP022686 | 2,780,110 | T→G | 5.9% | F677C (TTT→TGT) | metE → | 5‑methyltetrahydropteroyltriglutamate‑‑ homocysteine S‑methyltransferase |
RA | NZ_CP022686 | 2,808,127 | T→G | 8.2% | V441G (GTC→GGC) | ubiB → | ubiquinone biosynthesis regulatory protein kinase UbiB |
RA | NZ_CP022686 | 2,821,647 | G→C | 5.6% | intergenic (+103/‑275) | hemG → / → CIW80_RS14130 | menaquinone‑dependent protoporphyrinogen IX dehydrogenase/16S ribosomal RNA |
RA | NZ_CP022686 | 2,834,886 | A→C | 12.3% | K597N (AAA→AAC) | polA → | DNA polymerase I |
RA | NZ_CP022686 | 2,834,898 | A→C | 8.4% | K601N (AAA→AAC) | polA → | DNA polymerase I |
RA | NZ_CP022686 | 2,868,740 | T→G | 21.8% | Q22P (CAG→CCG) | fdoH ← | formate dehydrogenase O subunit beta |
RA | NZ_CP022686 | 2,868,742 | A→C | 11.0% | P21P (CCT→CCG) | fdoH ← | formate dehydrogenase O subunit beta |
RA | NZ_CP022686 | 2,868,745 | C→G | 8.1% | A20A (GCG→GCC) | fdoH ← | formate dehydrogenase O subunit beta |
RA | NZ_CP022686 | 2,868,753 | T→G | 11.6% | T18P (ACC→CCC) | fdoH ← | formate dehydrogenase O subunit beta |
RA | NZ_CP022686 | 2,871,449 | T→G | 7.7% | D140A (GAC→GCC) | fdnG ← | formate dehydrogenase‑N subunit alpha |
RA | NZ_CP022686 | 2,874,073 | A→C | 6.2% | T62P (ACC→CCC) | CIW80_RS14390 → | carbohydrate porin |
RA | NZ_CP022686 | 2,913,769 | A→C | 8.6% | H611P (CAC→CCC) | metL → | bifunctional aspartate kinase/homoserine dehydrogenase II |
RA | NZ_CP022686 | 2,920,385 | C→A | 7.5% | A54E (GCA→GAA) | CIW80_RS14610 → | bifunctional UDP‑sugar hydrolase/5'‑nucleotidase |
RA | NZ_CP022686 | 2,961,318 | A→C | 7.7% | intergenic (+96/‑277) | murI → / → CIW80_RS14765 | glutamate racemase/16S ribosomal RNA |
RA | NZ_CP022686 | 2,981,597 | G→T | 12.7% | E562* (GAA→TAA) | rpoC → | DNA‑directed RNA polymerase subunit beta' |
RA | NZ_CP022686 | 2,989,627 | T→G | 7.2% | Q39H (CAA→CAC) | thiC ← | phosphomethylpyrimidine synthase ThiC |
RA | NZ_CP022686 | 3,017,622 | A→C | 11.8% | K839N (AAA→AAC) | metH → | methionine synthase |
RA | NZ_CP022686 | 3,020,229 | T→G | 9.1% | V133G (GTC→GGC) | yjbB → | Na/Pi cotransporter family protein |
RA | NZ_CP022686 | 3,071,004 | T→G | 6.9% | G59G (GGT→GGG) | CIW80_RS15290 → | 2‑oxoglutarate dehydrogenase E1 component |
RA | NZ_CP022686 | 3,130,209 | A→C | 10.8% | V240G (GTC→GGC) | alsC ← | D‑allose ABC transporter permease |
RA | NZ_CP022686 | 3,136,923 | A→C | 9.0% | S167A (TCG→GCG) | phnN ← | ribose 1,5‑bisphosphokinase |
RA | NZ_CP022686 | 3,136,940 | T→G | 10.0% | D161A (GAC→GCC) | phnN ← | ribose 1,5‑bisphosphokinase |
RA | NZ_CP022686 | 3,163,655 | T→G | 6.1% | V300G (GTC→GGC) | melA → | alpha‑galactosidase |
RA | NZ_CP022686 | 3,184,639 | A→C | 7.5% | intergenic (‑86/+30) | cutA ← / ← dcuA | divalent cation tolerance protein CutA/anaerobic C4‑dicarboxylate transporter DcuA |
JC | NZ_CP022686 | 3,196,873 | +GCGTAATCGGTT | 100% | coding (944/1122 nt) | ampC ← | BlaEC family class C beta‑lactamase |
RA | NZ_CP022686 | 3,200,595 | A→C | 6.7% | V199G (GTT→GGT) | frdA ← | fumarate reductase (quinol) flavoprotein subunit |
RA | NZ_CP022686 | 3,209,153 | T→G | 6.0% | N225T (AAC→ACC) | rsgA ← | small ribosomal subunit biogenesis GTPase RsgA |
RA | NZ_CP022686 | 3,218,260 | T→G | 6.0% | L233R (CTT→CGT) | miaA → | tRNA (adenosine(37)‑N6)‑dimethylallyltransferase MiaA |
RA | NZ_CP022686 | 3,265,096 | G→T | 17.1% | A73E (GCA→GAA) | ytfJ ← | YtfJ family protein |
RA | NZ_CP022686 | 3,281,062 | T→G | 9.4% | V94G (GTG→GGG) | yjfF → | sugar ABC transporter permease YjfF |
RA | NZ_CP022686 | 3,348,342 | A→T | 7.0% | intergenic (‑158/‑42) | CIW80_RS16685 ← / → CIW80_RS26495 | inovirus Gp2 family protein/hypothetical protein |
RA | NZ_CP022686 | 3,348,345 | G→T | 8.2% | intergenic (‑161/‑39) | CIW80_RS16685 ← / → CIW80_RS26495 | inovirus Gp2 family protein/hypothetical protein |
RA | NZ_CP022686 | 3,348,371 | T→G | 9.0% | intergenic (‑187/‑13) | CIW80_RS16685 ← / → CIW80_RS26495 | inovirus Gp2 family protein/hypothetical protein |
RA | NZ_CP022686 | 3,387,616 | G→T | 6.4% | I231I (ATC→ATA) | sgcQ ← | BtpA family protein SgcQ |
RA | NZ_CP022686 | 3,387,644 | A→C | 7.8% | L222R (CTG→CGG) | sgcQ ← | BtpA family protein SgcQ |
RA | NZ_CP022686 | 3,424,795 | A→C | 100% | intergenic (‑41/+27) | yjiJ ← / ← yjiK | MFS transporter/YjiK family protein |
RA | NZ_CP022686 | 3,444,704 | T→G | 16.2% | T530P (ACC→CCC) | btsT ← | pyruvate/proton symporter BtsT |
RA | NZ_CP022686 | 3,444,711 | C→A | 9.8% | L527L (CTG→CTT) | btsT ← | pyruvate/proton symporter BtsT |
RA | NZ_CP022686 | 3,451,834 | C→A | 10.0% | H275N (CAT→AAT) | lgoD → | L‑galactonate oxidoreductase |
RA | NZ_CP022686 | 3,461,215 | A→T | 14.6% | intergenic (‑24/+11) | CIW80_RS17335 ← / ← CIW80_RS17340 | tRNA‑Leu/tRNA‑Leu |
RA | NZ_CP022686 | 3,461,229 | T→G | 21.9% | noncoding (84/87 nt) | CIW80_RS17340 ← | tRNA‑Leu |
RA | NZ_CP022686 | 3,461,231 | C→G | 11.7% | noncoding (82/87 nt) | CIW80_RS17340 ← | tRNA‑Leu |
RA | NZ_CP022686 | 3,496,452 | A→C | 11.0% | I273L (ATC→CTC) | thrA → | bifunctional aspartate kinase/homoserine dehydrogenase I |
RA | NZ_CP022686 | 3,496,461 | T→G | 12.1% | F276V (TTT→GTT) | thrA → | bifunctional aspartate kinase/homoserine dehydrogenase I |
RA | NZ_CP022686 | 3,504,054 | T→G | 9.5% | V204G (GTT→GGT) | tal → | transaldolase |
RA | NZ_CP022686 | 3,516,069 | T→G | 6.7% | V211G (GTT→GGT) | nhaA → | Na+/H+ antiporter NhaA |
RA | NZ_CP022686 | 3,528,214 | A→C | 7.9% | T56P (ACC→CCC) | carB → | carbamoyl‑phosphate synthase large subunit |
RA | NZ_CP022686 | 3,570,234 | T→G | 6.7% | L217V (TTG→GTG) | yabI → | DedA family protein |
RA | NZ_CP022686 | 3,604,564 | G→T | 16.9% | intergenic (+80/‑151) | lpxC → / → secM | UDP‑3‑O‑acyl‑N‑acetylglucosamine deacetylase/secA translation cis‑regulator SecM |
RA | NZ_CP022686 | 3,652,079 | T→G | 9.9% | intergenic (‑88/+24) | panB ← / ← CIW80_RS18255 | 3‑methyl‑2‑oxobutanoate hydroxymethyltransferase/fimbrial‑like adhesin |
RA | NZ_CP022686 | 3,656,188 | A→G | 100% | S549P (TCC→CCC) | htrE ← | outer membrane usher protein |
RA | NZ_CP022686 | 3,731,466 | T→C | 60.0% | intergenic (+20/‑35) | rrf → / → CIW80_RS18620 | 5S ribosomal RNA/tRNA‑Asp |
RA | NZ_CP022686 | 3,731,470 | C→T | 60.0% | intergenic (+24/‑31) | rrf → / → CIW80_RS18620 | 5S ribosomal RNA/tRNA‑Asp |
RA | NZ_CP022686 | 3,734,367 | T→G | 17.6% | F225V (TTT→GTT) | yafD → | endonuclease/exonuclease/phosphatase family protein |
RA | NZ_CP022686 | 3,734,380 | T→G | 16.1% | L229R (CTC→CGC) | yafD → | endonuclease/exonuclease/phosphatase family protein |
RA | NZ_CP022686 | 3,770,508 | T→G | 8.2% | intergenic (‑244/+219) | CIW80_RS26265 ← / ← CIW80_RS18890 | ATP‑binding protein/hypothetical protein |
RA | NZ_CP022686 | 3,770,524 | T→G | 8.9% | intergenic (‑260/+203) | CIW80_RS26265 ← / ← CIW80_RS18890 | ATP‑binding protein/hypothetical protein |
RA | NZ_CP022686 | 3,792,805 | A→G | 100% | Y421C (TAC→TGC) | fucP → | L‑fucose:H+ symporter permease |
RA | NZ_CP022686 | 3,797,481 | T→G | 19.7% | L130V (TTA→GTA) ‡ | CIW80_RS19065 → | LacI family DNA‑binding transcriptional regulator |
RA | NZ_CP022686 | 3,797,483 | A→T | 12.8% | L130F (TTA→TTT) ‡ | CIW80_RS19065 → | LacI family DNA‑binding transcriptional regulator |
RA | NZ_CP022686 | 3,797,493 | G→T | 13.8% | G134C (GGT→TGT) | CIW80_RS19065 → | LacI family DNA‑binding transcriptional regulator |
RA | NZ_CP022686 | 3,797,544 | C→A | 8.3% | P151T (CCT→ACT) | CIW80_RS19065 → | LacI family DNA‑binding transcriptional regulator |
RA | NZ_CP022686 | 3,801,492 | T→G | 6.6% | pseudogene (1768/1773 nt) | CIW80_RS19080 → | ShlB/FhaC/HecB family hemolysin secretion/activation protein |
RA | NZ_CP022686 | 3,824,332 | T→G | 8.5% | A217A (GCT→GCG) | CIW80_RS19155 → | TolC family protein |
RA | NZ_CP022686 | 3,868,846 | T→G | 10.8% | T383P (ACG→CCG) | ecpC ← | fimbrial usher EcpC |
RA | NZ_CP022686 | 3,895,534 | T→G | 9.3% | intergenic (‑140/+44) | CIW80_RS19510 ← / ← CIW80_RS19515 | protein YkgH/autotransporter outer membrane beta‑barrel domain‑containing protein |
RA | NZ_CP022686 | 3,925,289 | A→C | 13.7% | N156T (AAC→ACC) | prpC → | 2‑methylcitrate synthase |
RA | NZ_CP022686 | 3,928,345 | T→G | 9.3% | F277V (TTC→GTC) | prpE → | propionate‑‑CoA ligase |
RA | NZ_CP022686 | 3,935,324 | T→G | 12.0% | N705T (AAC→ACC) | lacZ ← | beta‑galactosidase |
RA | NZ_CP022686 | 3,937,229 | A→C | 8.0% | V70G (GTG→GGG) | lacZ ← | beta‑galactosidase |
RA | NZ_CP022686 | 3,940,707 | A→C | 12.8% | F314V (TTT→GTT) | frmA ← | S‑(hydroxymethyl)glutathione dehydrogenase |
RA | NZ_CP022686 | 3,940,724 | A→C | 9.0% | V308G (GTA→GGA) | frmA ← | S‑(hydroxymethyl)glutathione dehydrogenase |
RA | NZ_CP022686 | 3,942,556 | T→G | 6.0% | T121P (ACG→CCG) | yaiO ← | YaiO family outer membrane beta‑barrel protein |
RA | NZ_CP022686 | 3,977,611 | A→C | 7.7% | E73D (GAA→GAC) | phoR → | phosphate regulon sensor histidine kinase PhoR |
RA | NZ_CP022686 | 3,981,933 | T→G | 7.2% | intergenic (+70/‑86) | proY → / → malZ | proline‑specific permease ProY/maltodextrin glucosidase |
RA | NZ_CP022686 | 3,984,841 | T→G | 8.2% | R67R (CGT→CGG) | queA → | tRNA preQ1(34) S‑adenosylmethionine ribosyltransferase‑isomerase QueA |
RA | NZ_CP022686 | 4,014,238 | C→G | 10.9% | intergenic (+84/‑260) | bolA → / → tig | transcriptional regulator BolA/trigger factor |
RA | NZ_CP022686 | 4,014,242 | A→T | 10.5% | intergenic (+88/‑256) | bolA → / → tig | transcriptional regulator BolA/trigger factor |
RA | NZ_CP022686 | 4,014,250 | C→G | 8.7% | intergenic (+96/‑248) | bolA → / → tig | transcriptional regulator BolA/trigger factor |
RA | NZ_CP022686 | 4,014,291 | G→T | 19.5% | intergenic (+137/‑207) | bolA → / → tig | transcriptional regulator BolA/trigger factor |
RA | NZ_CP022686 | 4,032,276 | G→T | 14.8% | R101L (CGT→CTT) | glnK → | P‑II family nitrogen regulator |
RA | NZ_CP022686 | 4,056,942 | C→G | 7.5% | R131G (CGT→GGT) | adk → | adenylate kinase |
RA | NZ_CP022686 | 4,056,962 | C→A | 18.1% | F137L (TTC→TTA) | adk → | adenylate kinase |
RA | NZ_CP022686 | 4,056,987 | G→C | 8.0% | D146H (GAC→CAC) | adk → | adenylate kinase |
RA | NZ_CP022686 | 4,151,277 | T→G | 6.5% | T73P (ACC→CCC) | fepB ← | Fe2+‑enterobactin ABC transporter substrate‑binding protein |
RA | NZ_CP022686 | 4,213,260 | T→G | 7.0% | C188W (TGT→TGG) | ubiF → | 3‑demethoxyubiquinol 3‑hydroxylase |
RA | NZ_CP022686 | 4,214,435 | G→C | 8.1% | intergenic (‑8/+27) | CIW80_RS21095 ← / ← CIW80_RS21100 | tRNA‑Gln/tRNA‑Gln |
RA | NZ_CP022686 | 4,214,457 | G→T | 8.6% | intergenic (‑30/+5) | CIW80_RS21095 ← / ← CIW80_RS21100 | tRNA‑Gln/tRNA‑Gln |
RA | NZ_CP022686 | 4,290,599 | T→G | 6.9% | T121P (ACC→CCC) | ybgS ← | YbgS‑like family protein |
RA | NZ_CP022686 | 4,368,341 | T→G | 13.3% | D47A (GAC→GCC) | ybiY ← | glycyl‑radical enzyme activating protein |
RA | NZ_CP022686 | 4,368,380 | T→G | 11.9% | N34T (AAC→ACC) | ybiY ← | glycyl‑radical enzyme activating protein |
RA | NZ_CP022686 | 4,412,284 | A→C | 10.6% | W241G (TGG→GGG) | ybjT ← | SDR family oxidoreductase |
RA | NZ_CP022686 | 4,440,324 | C→A | 11.4% | P794Q (CCG→CAG) | ftsK → | DNA translocase FtsK |
RA | NZ_CP022686 | 4,440,334 | A→T | 20.1% | Q797H (CAA→CAT) | ftsK → | DNA translocase FtsK |
RA | NZ_CP022686 | 4,562,600 | T→G | 12.4% | Q123P (CAG→CCG) | putA ← | trifunctional transcriptional regulator/proline dehydrogenase/L‑glutamate gamma‑semialdehyde dehydrogenase |
RA | NZ_CP022686 | 4,571,417 | T→G | 7.9% | A66A (GCA→GCC) | pgaC ← | poly‑beta‑1,6‑N‑acetyl‑D‑glucosamine synthase |
RA | NZ_CP022686 | 4,571,439 | T→G | 7.4% | H59P (CAC→CCC) | pgaC ← | poly‑beta‑1,6‑N‑acetyl‑D‑glucosamine synthase |
RA | NZ_CP022686 | 4,571,454 | A→C | 7.8% | V54G (GTC→GGC) | pgaC ← | poly‑beta‑1,6‑N‑acetyl‑D‑glucosamine synthase |
RA | NZ_CP022686 | 4,587,091 | T→G | 13.3% | N609T (AAC→ACC) | CIW80_RS22915 ← | enterotoxin |
RA | NZ_CP022686 | 4,605,584 | C→G | 8.3% | R54P (CGC→CCC) | CIW80_RS23010 ← | hypothetical protein |
RA | NZ_CP022686 | 4,605,593 | T→G | 9.1% | Q51P (CAG→CCG) | CIW80_RS23010 ← | hypothetical protein |
RA | NZ_CP022686 | 4,632,182 | T→G | 10.8% | R276R (CGT→CGG) | mchF → | microcin export transporter peptidase/ATP‑binding subunit MchF |
RA | NZ_CP022686 | 4,642,951 | A→C | 8.9% | N732T (AAC→ACC) | sfaF → | S/F1C fimbrial usher SfaF/FocD |
RA | NZ_CP022686 | 4,678,041 | A→C | 21.6% | intergenic (+39/‑82) | agn43 → / → CIW80_RS23450 | autotransporter adhesin Ag43/hypothetical protein |
RA | NZ_CP022686 | 4,678,108 | C→A | 6.3% | intergenic (+106/‑15) | agn43 → / → CIW80_RS23450 | autotransporter adhesin Ag43/hypothetical protein |
RA | NZ_CP022686 | 4,681,602 | G→T | 5.6% | G8C (GGT→TGT) | CIW80_RS23465 → | DUF932 domain‑containing protein |
RA | NZ_CP022686 | 4,759,434 | C→A | 5.7% | L199F (TTG→TTT) | ldtC ← | L,D‑transpeptidase LdtC |
RA | NZ_CP022686 | 4,764,904 | G→T | 7.3% | intergenic (‑84/‑177) | ycfT ← / → lolC | acyltransferase family protein/lipoprotein‑releasing ABC transporter permease subunit LolC |
RA | NZ_CP022686 | 4,780,176 | A→C | 14.1% | intergenic (‑75/+95) | phoP ← / ← purB | two‑component system response regulator PhoP/adenylosuccinate lyase |
RA | NZ_CP022686 | 4,809,441 | T→G | 5.1% | G50G (GGT→GGG) | CIW80_RS24260 → | head‑tail joining protein |
RA | NZ_CP022686 | 4,814,961 | T→G | 9.8% | F61C (TTT→TGT) | CIW80_RS24295 → | phage tail protein |
RA | NZ_CP022686 | 4,814,963 | C→G | 7.6% | L62V (CTG→GTG) | CIW80_RS24295 → | phage tail protein |
RA | NZ_CP022686 | 4,814,990 | T→G | 10.2% | F71V (TTT→GTT) | CIW80_RS24295 → | phage tail protein |
RA | NZ_CP022686 | 4,815,886 | T→G | 9.3% | V25G (GTG→GGG) | CIW80_RS24305 → | C40 family peptidase |
RA | NZ_CP022686 | 4,839,668 | T→G | 12.7% | V150V (GTA→GTC) | minD ← | septum site‑determining protein MinD |
RA | NZ_CP022686 | 4,839,687 | T→G | 12.1% | N144T (AAC→ACC) | minD ← | septum site‑determining protein MinD |
RA | NZ_CP022686 | 4,845,144 | A→C | 6.4% | L101L (CTA→CTC) | umuD → | translesion error‑prone DNA polymerase V autoproteolytic subunit |
RA | NZ_CP022686 | 4,870,912 | Δ1 bp | 100% | intergenic (‑108/‑120) | dhaK ← / → dhaR | dihydroxyacetone kinase subunit DhaK/dihydroxyacetone kinase operon transcriptional regulator DhaR |
RA | NZ_CP022686 | 4,905,170 | T→G | 16.4% | V99G (GTT→GGT) | CIW80_RS24815 → | coenzyme F390 synthetase |
RA | NZ_CP022686 | 4,909,108 | A→T | 9.2% | intergenic (‑5/+42) | CIW80_RS24835 ← / ← CIW80_RS24840 | RtT sRNA/tRNA‑Tyr |
RA | NZ_CP022686 | 4,919,017 | T→G | 7.6% | E330D (GAA→GAC) | adhE ← | bifunctional acetaldehyde‑CoA/alcohol dehydrogenase |
RA | NZ_CP022686 | 4,951,538 | C→A | 20.4% | A44A (GCC→GCA) | topA → | type I DNA topoisomerase |
RA | NZ_CP022686 | 5,042,289 | T→C | 8.0% | N640N (AAT→AAC) | CIW80_RS25525 → | EntS/YbdA MFS transporter |
RA | NZ_CP022686 | 5,043,558 | T→C | 6.7% | S1063S (AGT→AGC) | CIW80_RS25525 → | EntS/YbdA MFS transporter |
RA | NZ_CP022686 | 5,043,648 | G→C | 7.1% | V1093V (GTG→GTC) | CIW80_RS25525 → | EntS/YbdA MFS transporter |
RA | NZ_CP022686 | 5,044,014 | T→A | 7.4% | V1215V (GTT→GTA) | CIW80_RS25525 → | EntS/YbdA MFS transporter |
RA | NZ_CP022686 | 5,044,137 | G→T | 12.9% | V1256V (GTG→GTT) | CIW80_RS25525 → | EntS/YbdA MFS transporter |
RA | NZ_CP022686 | 5,044,182 | T→A | 9.5% | G1271G (GGT→GGA) | CIW80_RS25525 → | EntS/YbdA MFS transporter |
RA | NZ_CP022686 | 5,044,215 | T→G | 12.5% | N1282K (AAT→AAG) | CIW80_RS25525 → | EntS/YbdA MFS transporter |
RA | pMut‑Ompa‑D5‑IL2wt‑His6 | 2,031 | G→A | 100% | intergenic (‑235/‑1500) | putative rom (RNA I inhibition modulator protein) ← / → ompA | –/– |
RA | pMut‑Ompa‑D5‑IL2wt‑His6 | 3,484 | T→G | 13.0% | intergenic (‑1688/‑47) | putative rom (RNA I inhibition modulator protein) ← / → ompA | –/– |
JC | pMut‑Ompa‑D5‑IL2wt‑His6 | 3,595 | Δ15 bp | 100% | [IL2wt no signal] | [IL2wt no signal] | |
RA | pMut‑Ompa‑D5‑IL2wt‑His6 | 3,762 | G→T | 33.0% | E52* (GAA→TAA) | IL2wt no signal → | |
RA | pMut‑Ompa‑D5‑IL2wt‑His6 | 3,792 | G→T | 7.3% | E62* (GAA→TAA) | IL2wt no signal → | |
JC | pMut‑Ompa‑D5‑IL2wt‑His6 | 4,019 | +CAT | 8.1% | intergenic (+12/+37) | IL2wt no signal → / ← annotated as hok_sok locus | –/– |
Unassigned missing coverage evidence | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
seq id | start | end | size | ←reads | reads→ | gene | description | |||
* | * | ÷ | NZ_MW240712 | 663–2618 | 3067–2957 | 340–2405 | 8163 [7533] | [7770] 7958 | JNG15_RS00010–mobA | JNG15_RS00010,JNG15_RS00015,mobA |
* | * | ÷ | pMut‑Ompa‑D5‑IL2wt‑His6 | 4745–4809 | 5478–5214 | 406–734 | 5268 [5245] | [0] NA | [putative HTH domain protein] | [putative HTH domain protein] |
Unassigned new junction evidence | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
* | ? | NZ_CP022686 | 1415492 = | 171 (0.710) | 11 (0.050) | 9/246 | NT | 6.1% | coding (468/531 nt) | emrR | multidrug efflux transporter EmrAB transcriptional repressor EmrR |
? | NZ_CP022686 | = 1761695 | NA (NA) | intergenic (‑70/‑72) | CIW80_RS08710/CIW80_RS08720 | IS3‑like element ISEc52 family transposase/IS3‑like element IS600 family transposase | |||||
* | ? | NZ_CP022686 | = 1415498 | 170 (0.700) | 19 (0.080) | 15/246 | NT | 10.2% | coding (474/531 nt) | emrR | multidrug efflux transporter EmrAB transcriptional repressor EmrR |
? | NZ_CP022686 | = 1524128 | NA (NA) | intergenic (+6/+234) | CIW80_RS07590/syd | IS3‑like element ISEc52 family transposase/SecY‑interacting protein | |||||
* | ? | NZ_CP022686 | = 2700948 | NA (NA) | 43 (0.010) +23 bp |
23/204 | NT | 89.8% | intergenic (+11/+6) | CIW80_RS13525/mdtD | IS3‑like element ISEc52 family transposase/multidrug transporter subunit MdtD |
? | pMut‑Ompa‑D5‑IL2wt‑His6 | = 3594 | 6 (0.000) | intergenic (+1/‑15) | ompA/IL2wt no signal | –/– | |||||
* | ? | NZ_CP022686 | 3899666 = | 255 (1.050) | 78 (0.370) | 41/218 | NT | 27.5% | intergenic (‑40/+290) | hyxR/ipbA | LuxR family transcriptional regulator HyxR/tyrosine‑type DNA invertase IpbA |
? | NZ_CP022686 | 3899944 = | 190 (0.900) | intergenic (‑318/+12) | hyxR/ipbA | LuxR family transcriptional regulator HyxR/tyrosine‑type DNA invertase IpbA | |||||
* | ? | NZ_CP022686 | = 3899681 | 245 (1.010) | 80 (0.380) | 43/218 | NT | 28.4% | intergenic (‑55/+275) | hyxR/ipbA | LuxR family transcriptional regulator HyxR/tyrosine‑type DNA invertase IpbA |
? | NZ_CP022686 | = 3899927 | 190 (0.900) | intergenic (‑301/+29) | hyxR/ipbA | LuxR family transcriptional regulator HyxR/tyrosine‑type DNA invertase IpbA | |||||
* | ? | NZ_CP022686 | 4514374 = | 234 (0.970) | 10 (0.000) +AGCT |
8/242 | NT | 7.9% | coding (59/1053 nt) | ompA | porin OmpA |
? | pMut‑Ompa‑D5‑IL2wt‑His6 | 3609 = | 6 (0.000) | coding (1/399 nt) | IL2wt no signal | ||||||
* | ? | pMut‑Ompa‑D5‑IL2wt‑His6 | = 1761 | 0 (0.000) | 3 (0.000) | 3/246 | NT | 100% | coding (36/195 nt) | putative rom (RNA I inhibition modulator protein) | |
? | pMut‑Ompa‑D5‑IL2wt‑His6 | 1765 = | NA (NA) | coding (32/195 nt) | putative rom (RNA I inhibition modulator protein) |